Accrol Group Holdings PLC Appointment of Joint Broker (3149G)

TIDMACRL

RNS Number : 3149G

Accrol Group Holdings PLC

17 March 2020

Accrol Group Holdings plc

(AIM: ACRL)

Appointment of Joint Broker

Accrol Group Holdings plc (the "Company" or "Accrol"), the UK's leading independent tissue converter, is pleased to announce the appointment of Liberum Capital Limited as joint broker to the Company with immediate effect.

 
For further information, please contact: 
 
Accrol Group Holdings plc 
Dan Wright, Executive Chairman               Tel: +44 (0) 1254 278 
                                                               844 
Gareth Jenkins, Chief Executive Officer 
 
Zeus Capital Limited (Nominated Adviser 
 & Broker) 
Dan Bate / Andrew Jones                       Tel: +44 (0) 161 831 
                                                              1512 
Dominic King / John Goold                     Tel: +44 (0) 203 829 
                                                              5000 
 
Liberum Capital Limited (Joint Broker) 
Clayton Bush / Edward Thomas                  Tel: +44 (0) 20 3100 
                                                              2000 
 
Belvedere Communications Limited 
Cat Valentine                                Tel: +44 (0) 7715 769 
                                                               078 
Keeley Clarke                                Tel: +44 (0) 7967 816 
                                                               525 
Llew Angus                                   Tel: +44 (0) 7407 023 
                                                               147 
                                          AccrolPR@BelvederePR.com

Notes to Editors

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK.

The business operates from four sites in Lancashire:

   --      A manufacturing, storage and distribution facility in Blackburn; 
   --      A storage and administrative centre in Blackburn; 
   --      A facial tissue plant, also in Blackburn; and 
   --      A manufacturing, storage and distribution facility in Leyland.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

APPBSGDXRBBDGGL

(END) Dow Jones Newswires

March 17, 2020 03:00 ET (07:00 GMT)

Accrol (LSE:ACRL)
Historical Stock Chart
From Apr 2024 to May 2024